Form 4: Cardlytics Officer Reports RSU Vesting & Tax Sale

Cardlytics Chief Legal & Privacy Officer, Nicholas Lynton, reported the vesting of restricted stock units and a subsequent sale of shares to cover tax withholding obligations.

Summary

• Nicholas Lynton, Chief Legal & Privacy Officer and Director of Cardlytics, Inc. (CDLX), reported transactions involving company stock.
• On October 1, 2025, a total of 12,789 shares of Common Stock were acquired through the vesting of Restricted Stock Units (RSUs).
• These RSUs originated from three separate awards, with initial grants of 85,035, 9,299, and 25,247 shares, vesting over various schedules.
• On October 2, 2025, Lynton sold 6,098 shares of Common Stock at a weighted average price of $2.271 per share.
• The sale was exclusively to satisfy tax withholding obligations arising from the RSU vesting, with no other purpose for the disposition.
• Following these transactions, Lynton directly beneficially owns 116,327 shares of Common Stock.
• He also holds 27,156 Restricted Stock Units that have not yet vested.

Sentiment

Score: 6

Explanation: The filing reports routine insider transactions related to executive compensation. The vesting of RSUs is positive for the executive and indicates retention, while the sale of shares is explicitly for tax purposes, which is a neutral event in terms of market sentiment. No strategic or operational news is present, thus a moderate score.

Positives

• The vesting of 12,789 Restricted Stock Units indicates continued compensation and retention of a key executive.
• The executive's beneficial ownership of 116,327 common shares and additional unvested RSUs demonstrates alignment with shareholder interests.

Negatives

• The sale of 6,098 shares, even for tax purposes, reduces the executive's direct equity stake in the company.

Risks

• NA

Future Outlook

The reporting person has additional Restricted Stock Units scheduled to vest in future installments, contingent upon continued employment or service to Cardlytics, Inc. These include installments from an 85,035-share award vesting quarterly until April 1, 2026, and remaining quarterly vesting from 9,299-share and 25,247-share awards over subsequent years.

Management Comments

• Shares were sold solely to satisfy tax withholding obligations that resulted from the delivery of shares of common stock for RSUs that vested on October 1, 2025. The Reporting Person did not sell shares for any other purpose.

Industry Context

This filing represents a routine insider transaction related to executive compensation, specifically the vesting of equity awards and subsequent tax-related sales. Such transactions are common across publicly traded companies as part of their executive compensation structures and do not typically indicate a shift in broader industry trends or competitive landscape.

Comparison to Industry Standards

• NA

Stakeholder Impact

• Shareholders: Minor, routine dilution from RSU vesting is offset by the executive's continued equity stake. The tax-related sale is a common occurrence and not indicative of a lack of confidence.
• Employees: The vesting of equity awards reinforces the company's compensation structure for key personnel.

Next Steps

• Continued employment of Nicholas Lynton with Cardlytics, Inc. to ensure future RSU vesting.
• Future quarterly vesting of remaining Restricted Stock Units from the 85,035-share award until April 1, 2026.
• Future quarterly vesting of remaining Restricted Stock Units from the 9,299-share and 25,247-share awards over the subsequent three years.

Key Dates

Recommendation

This Form 4 filing details routine insider transactions involving the vesting of Restricted Stock Units and a subsequent sale of shares solely to cover tax withholding obligations. These events are standard practice for executive compensation and do not provide new information regarding the company's operational performance, strategic direction, or financial health that would warrant a change in investment recommendation. The executive maintains a significant beneficial ownership, aligning interests with shareholders.

Keywords

Cardlytics, CDLX, Nicholas Lynton, Insider Transaction, Form 4, Restricted Stock Units, RSU Vesting, Share Sale, Tax Withholding, Officer Compensation